Laparoscopic sleeve gastrectomy was associated with the development of new-onset gastroesophageal reflux disease in 26.7% of patients with severe obesity within 6 months postoperatively.
Observational (n=60)
No
What is the incidence of de novo gastroesophageal reflux disease (GERD) in patients with severe obesity undergoing laparoscopic sleeve gastrectomy?
Laparoscopic sleeve gastrectomy is associated with a 26.7% incidence of de novo GERD within the first 6 months, highlighting the need for thorough preoperative screening.
Abstract Background The escalating global prevalence of obesity presents a significant public health concern, driving increased rates of obesity-associated comorbidities. Timely identification and management are essential to reduce long-term health and economic consequences. Objective This study sought to evaluate the short-term emergence of gastroesophageal reflux disease (GERD) in patients with severe obesity undergoing laparoscopic sleeve gastrectomy (LSG) early in the first 6 months postoperatively. Methods We conducted a prospective case series involving 60 patients with severe obesity who received LSG at the Bariatric Surgery Unit, Department of Surgery, Ain Shams University Hospitals (June 2018—June 2021). Postoperative follow-up included clinical evaluation and diagnostic testing to detect new-onset GERD. Results GERD developed in 26.7% of patients (16 of 60) following LSG. Based on these findings, LSG should be avoided in individuals with preoperative evidence of erosive esophagitis, Barrett’s esophagus, or an incompetent lower esophageal sphincter (LES), where Roux-en-Y gastric bypass may represent a more suitable alternative. For selected patients with a BMI of 30–35 and associated comorbidities, LSG combined with anti-reflux procedures or concurrent hiatal hernia repair could be considered. Conclusion The study reinforces the need for thorough preoperative evaluation, including routine upper gastrointestinal endoscopy, to screen for GERD, hiatal hernia, and premalignant conditions. Careful patient selection and individualized surgical planning remain critical to optimizing outcomes after bariatric surgery.
Abdel-Salam et al. (Tue,) conducted a observational in Severe obesity (n=60). Laparoscopic sleeve gastrectomy was evaluated on New-onset gastroesophageal reflux disease (GERD). Laparoscopic sleeve gastrectomy was associated with the development of new-onset gastroesophageal reflux disease in 26.7% of patients with severe obesity within 6 months postoperatively.